Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
BMS is moving beyond conversational AI into what it describes as “agentic” systems
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Subscribe To Our Newsletter & Stay Updated